Sandoz repays existing bonds and issues new bonds

Share on:

Sandoz, a global leader in generics and biosimilars, has announced that it has fully repaid USD 750 million equivalent USD and EUR term loans that were put in place in September 2023, just before its spin-off from Novartis. The repayment was funded through proceeds from successful bond transactions:

– On 13 March 2025, Sandoz issued a three-year CHF 165 million and an eight-year CHF 253 million bond, with annual coupons of 2.125% and 1.75%, respectively.

– On 17 March 2025, Sandoz issued a single-tranche EUR 500 million bond with a 10-year tenor and an annual coupon of 4%.

In addition, a new USD 2 billion multi-currency revolving credit facility with five-year maturity and one-year extension option has been secured. It replaces the previously unused USD 1.25 billion revolving credit facility set up in 2023.

Discover more articles

We provide up-to-date information on legal and regulatory developments regarding the capital markets, publish concise articles on developments in the Swiss and international financial markets, and announce recent deals and forthcoming events.

  • Note from the Editors | Strengthening the “Too Big to Fail” Regime in Switzerland

    The collapse of Credit Suisse in March 2023 has served as a powerful catalyst for a renewed and intensified debate on the effectiveness of Switzerland’s ‘too big to fail’ (TBTF) regulatory framework. In response, the Swiss Federal Council has presented a comprehensive package of measures aimed at strengthening banking stability and mitigating the risks posed…


  • EARLY INTERVENTION REGIME

    On 6 June 2025, the Swiss Federal Council published proposed additional powers for the Swiss Financial Market Supervisory Authority FINMA. This article assesses the intended early intervention regime.


  • A “Swiss Senior Managers Regime”: Less Is More

    The Federal Council welcomes the introduction of a supervisory regime for senior managers of Swiss banks, citing perceived gaps in regulatory accountability. In fact, what is needed is not a new regulatory regime modelled on the British “senior managers regime”, but rather clarification and refinement of the current framework.


  • The Proposal to Grant FINMA the Power to Impose Fines

    This article examines the proposal to grant Swiss Financial Market Supervisory Authority (FINMA) the power to impose fines. The initiative, once seen as unlikely, gained renewed attention after the collapse of Credit Suisse and has since been supported by FINMA and considered by the Federal Council and the Swiss Parliament. While proponents emphasise deterrence, international…


  • Idorsia Ltd’s Placement of 16.4 Million Shares through Accelerated Bookbuilding

    On 10 October 2025, Idorsia Ltd (SIX-listed) announced the launch of an accelerated bookbuilding offering, which led to the placement of 16.4 million shares at an offer price of CHF 4.00 per offered share, raising aggregate gross proceeds of approximately CHF 65.6 million. J.P. Morgan and UBS acted as Joint Bookrunners and Global Coordinators, and…


  • DocMorris Finance B.V.’s Placement of CHF 49.6 Million Convertible Bonds Due 2028 and Early Buyback of Convertible Bonds due 2026

    On 22 October 2025, DocMorris Finance B.V., a subsidiary of DocMorris AG (SIX: DOCM), placed EUR 49.6 million senior unsecured bonds due 2028 and convertible into shares of DocMorris AG. Further, in November 2025, DocMorris Finance B.V. conducted a tender offer for its outstanding convertible bonds due 2026 at 103.5% of the par value plus…